Full Product Name
Rabbit anti-Homo sapiens (Human) NHLRC1 Polyclonal antibody
Alternative Names
bA204B7.2 antibody; E3 ubiquitin-protein ligase NHLRC1 antibody; EPM2A antibody; EPM2B antibody; EPM2B gene antibody; Malin antibody; MGC119262 antibody; MGC119264 antibody; MGC119265 antibody; NHL repeat containing 1 antibody; NHL repeat containing E3 ubiquitin protein ligase 1 antibody; NHL repeat containing protein 1 antibody; NHL repeat-containing protein 1 antibody; NHL repeat-containing protein 1 gene antibody; NHLC1_HUMAN antibody; NHLRC 1 antibody; Nhlrc1 antibody
Species Reactivity
Human, Rat
Immunogen
Recombinant Human E3 ubiquitin-protein ligase NHLRC1 protein (1-280AA)
Immunogen Species
Homo sapiens (Human)
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Tested Applications
ELISA, WB, IHC
Recommended Dilution
Application |
Recommended Dilution |
WB |
1:1000-1:5000 |
IHC |
1:20-1:200 |
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Description
The product CSB-PA740936ESR2HU is a polyclonal antibody produced in the rabbit with recombinant human NHLRC1 protein (1-280AA) immunized. This antibody against NHLRC1 exists as an unconjugated IgG. It is purified by the antigen affinity method. It shows reactivity with human and rat NHLRC1, also called EPM2B, which is an E3 ubiquitin-protein ligase that is complexed with EPM2A/laforin and HSP70 to inhibit the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system (UPS). The NHLRC1 protein may play a vital role in the survival of neurons in the brain. This NHLRC1 antibody has been validated for use in ELISA, WB, and IHC applications.